Abstract:Globally, tuberculosis (TB) is a leading cause of death from a single infectious agent. Healthcare workers (HCWs) are at increased risk of hospital-acquired TB infection due to persistent exposure to Mycobacterium tuberculosis (Mtb) in healthcare settings. The World Health Organization (WHO) has developed an international system of infection prevention and control (IPC) interventions to interrupt the cycle of nosocomial TB transmission. The guidelines on TB IPC have proposed a comprehensive hierarchy of three core practices, comprising: administrative controls, environmental controls, and personal respiratory protection. However, the implementation of most recommendations goes beyond minimal physical and organisational requirements and thus cannot be appropriately introduced in resource-constrained settings and areas of high TB incidence. In many low- and middle-income countries (LMICs) the lack of knowledge, expertise and practice on TB IPC is a major barrier to the implementation of essential interventions. HCWs often underestimate the risk of airborne Mtb dissemination during tidal breathing. The lack of required expertise and funding to design, install and maintain the environmental control systems can lead to inadequate dilution of infectious particles in the air, and in turn, increase the risk of TB dissemination. Insufficient supply of particulate respirators and lack of direction on the re-use of respiratory protection is associated with unsafe working practices and increased risk of TB transmission between patients and HCWs. Delayed diagnosis and initiation of treatment are commonly influenced by the effectiveness of healthcare systems to identify TB patients, and the availability of rapid molecular diagnostic tools. Failure to recognise resistance to first-line drugs contributes to the emergence of drug-resistant Mtb strains, including multidrug-resistant and extensively drug-resistant Mtb. Future guideline development must consider the social, economic, cultural and climatic conditions to ensure that recommended control measures can be implemented in not only high-income countries, but more importantly low-income, high TB burden settings. Urgent action and more ambitious investments are needed at both regional and national levels to get back on track to reach the global TB targets, especially in the context of the COVID-19 pandemic.

New priorities for Croatia to pursue tuberculosis pre-elimination

Scaling up interventions to achieve global tuberculosis control: progress and new developments

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited

Stopping tuberculosis in the 21st century: Goals and strategies

Tuberculosis in the European Region

The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

New opportunities in tuberculosis prevention: implications for people living with HIV

Towards elimination of tuberculosis in New Zealand

Factors that influence current tuberculosis epidemiology

Analysis of the multi-drug resistant tuberculosis treatment outcomes: Experience from the special hospital for pulmonary diseases "Ozren" - Sokobanja

Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Reducing the risk of tuberculosis transmission for HCWs in high incidence settings

Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings

Achievements and topical issues in the field of prevention, diagnosis, and treatment of tuberculosis in children in the Republic of Moldova during the implementation of the “End tb strategy”

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

Evolution of WHO policies for tuberculosis control, 1948-2001

Tuberculosis Prevalence Trends from a Predictive Modelling Study - 10 High-Burden Countries, 1980-2035

Progress and challenges in achieving tuberculosis elimination in India by 2025: A systematic review and meta-analysis